Cost-effectiveness analysis of cemiplimab vs pembrolizumab for treatment of advanced cutaneous squamous cell carcinoma

by Atsou, K., Ayers, D., Chen, C.-I, Cope, S., Guyot, P., Keeping, S., Konidaris, G., Kuznik, A., Mojebi, A., Paul, E., Sasane, M., Xu, Y.
Published 2021